These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 32421156)
1. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion. De Vocht J; Blommaert J; Devrome M; Radwan A; Van Weehaeghe D; De Schaepdryver M; Ceccarini J; Rezaei A; Schramm G; van Aalst J; Chiò A; Pagani M; Stam D; Van Esch H; Lamaire N; Verhaegen M; Mertens N; Poesen K; van den Berg LH; van Es MA; Vandenberghe R; Vandenbulcke M; Van den Stock J; Koole M; Dupont P; Van Laere K; Van Damme P JAMA Neurol; 2020 Aug; 77(8):1008-1017. PubMed ID: 32421156 [TBL] [Abstract][Full Text] [Related]
5. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479 [TBL] [Abstract][Full Text] [Related]
6. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Cistaro A; Pagani M; Montuschi A; Calvo A; Moglia C; Canosa A; Restagno G; Brunetti M; Traynor BJ; Nobili F; Carrara G; Fania P; Lopiano L; Valentini MC; Chiò A Eur J Nucl Med Mol Imaging; 2014 May; 41(5):844-52. PubMed ID: 24445987 [TBL] [Abstract][Full Text] [Related]
7. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C; Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655 [TBL] [Abstract][Full Text] [Related]
8. FDG-PET in presymptomatic C9orf72 mutation carriers. Popuri K; Beg MF; Lee H; Balachandar R; Wang L; Sossi V; Jacova C; Baker M; Shahinfard E; Rademakers R; Mackenzie IRA; Hsiung GR Neuroimage Clin; 2021; 31():102687. PubMed ID: 34049163 [TBL] [Abstract][Full Text] [Related]
9. How can we define the presymptomatic C9orf72 disease in 2022? An overview on the current definitions of preclinical and prodromal phases. Saracino D; Le Ber I Rev Neurol (Paris); 2022 May; 178(5):426-436. PubMed ID: 35525633 [TBL] [Abstract][Full Text] [Related]
10. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the Devenney EM; Landin-Romero R; Irish M; Hornberger M; Mioshi E; Halliday GM; Kiernan MC; Hodges JR Neuroimage Clin; 2017; 13():439-445. PubMed ID: 28116236 [TBL] [Abstract][Full Text] [Related]
15. Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in Convery RS; Bocchetta M; Greaves CV; Moore KM; Cash DM; Van Swieten J; Moreno F; Sánchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD; J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1325-1328. PubMed ID: 32759310 [TBL] [Abstract][Full Text] [Related]
16. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers. Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838 [TBL] [Abstract][Full Text] [Related]
17. Plasma microRNA signature in presymptomatic and symptomatic subjects with Kmetzsch V; Anquetil V; Saracino D; Rinaldi D; Camuzat A; Gareau T; Jornea L; Forlani S; Couratier P; Wallon D; Pasquier F; Robil N; de la Grange P; Moszer I; Le Ber I; Colliot O; Becker E; J Neurol Neurosurg Psychiatry; 2021 May; 92(5):485-493. PubMed ID: 33239440 [TBL] [Abstract][Full Text] [Related]
18. Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Kertesz A; Ang LC; Jesso S; MacKinley J; Baker M; Brown P; Shoesmith C; Rademakers R; Finger EC Cogn Behav Neurol; 2013 Sep; 26(3):146-54. PubMed ID: 24077574 [TBL] [Abstract][Full Text] [Related]
19. von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion. Yang Y; Halliday GM; Hodges JR; Tan RH J Alzheimers Dis; 2017; 58(3):701-709. PubMed ID: 28482638 [TBL] [Abstract][Full Text] [Related]
20. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M; J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]